![]() |
|
|
|
You are here: Clinical Trials >
Information obtained from ClinicalTrials.gov on June 16, 2008 Link to the current ClinicalTrials.gov record. Condition(s) treated: Acne Papulopustulosa Intervention: Differin Gel (Drug) Phase: Phase 4 Enrollment status: Recruiting Sponsor: Dresden University of Technology
Principal investigator(s) or official(s):
Overall contact:
The aim of the study is to investigate the effectivity of visible light in combination with waterfiltered infrared in treating acne papulopustulosa. The reduction of inflammatory and non-inflammatory lesions within 8 weeks will be measured and compared with the standard treatment with Adapalene.
Official title: Control of Therapy of Acne Papulopustulosa by Visible Light With Waterfiltered Infrared and / or Adapalen (Differin Gel) Study design: Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study Primary outcome: reduction of inflammatory and non-inflammatory lesions within 8 weeks after start of therapy
Minimum eligible age: 14 Years. Eligible gender(s): Both. Criteria: Inclusion Criteria:
Roland Aschoff, MD, Phone: 0049-351-458, Ext: 2007, Email: Roland.Aschoff@mailbox.tu-dresden.de Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden, Dresden, Sachsen 01307, Germany; Recruiting
Start date: September 2006
Home | About Us | Contact Us | Ask a Question | Resources Copyright © 1999-2008 by Dr. G. Todorov / SmartSkinCare.com Site Disclaimer | Copyright Certification
|
|